Cell-based therapy for degenerative retinal disease /
General Material Designation
[Book]
First Statement of Responsibility
Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano, editors.
.PUBLICATION, DISTRIBUTION, ETC
Place of Publication, Distribution, etc.
Cham, Switzerland :
Name of Publisher, Distributor, etc.
Humana Press,
Date of Publication, Distribution, etc.
2019.
PHYSICAL DESCRIPTION
Specific Material Designation and Extent of Item
1 online resource (xi, 280 pages) :
Other Physical Details
illustrations (some color)
SERIES
Series Title
Stem cell biology and regenerative medicine,
ISSN of Series
2196-8985
GENERAL NOTES
Text of Note
Includes index.
CONTENTS NOTE
Text of Note
Intro; Preface; Contents; Contributors; Chapter 1: Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System; Introduction; Advantages of the Eye as a Target Organ; Anatomy and Physiology; Surgical Access; Immune Privilege; Antigen Load; High-Resolution Noninvasive Imaging Technology; Functional Assessment of the Transplant; Conclusions; References; Chapter 2: Proof of Principle: Preclinical Data on Retinal Cell Transplantation; Introduction; Photoreceptor Rescue Therapy; RPE Transplantation; Neural and Retinal Progenitor Cell Transplantation
Text of Note
Age-Related Macular DegenerationClinical Characteristics; Genetic Association and Pathophysiology; Ophthalmoscopic Features; Imaging and Other Useful Tests; Fluorescein Angiography; Optical Coherence Tomography; Fundus Autofluorescence; Electrophysiological Testing; Differential Diagnosis; ABCA4 (Stargardt) Dystrophy; Clinical Characteristics; Genetic Association and Pathophysiology; Ophthalmoscopic Features; Imaging and Other Useful Tests; Fundus Autofluorescence; Fluorescein Angiography; Optical Coherence Tomography; Electrophysiological Testing; Differential Diagnosis; Best Disease
Text of Note
Bone Marrow Cell TransplantationUmbilical Tissue-Derived Cell Transplantation; Photoreceptor Replacement Therapy; Neuroretinal Sheet Transplantation; Photoreceptor Cell Transplantation; Retinal Cellular Materials Transfer; Conclusion; References; Chapter 3: Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases; Introduction; Generalized Retinal Degenerations; Retinitis Pigmentosa; Clinical Characteristics; Genetic Associations and Pathophysiology; Ophthalmoscopic Features; Imaging and Other Useful Tests; Perimetry and Electrophysiological Testing
Fundus AutofluorescenceFluorescein Angiography; Optical Coherence Tomography (OCT); Differential Diagnosis; Leber Congenital Amaurosis; Clinical Characteristics; Genetic Association and Pathophysiology; Ophthalmoscopic Features; Imaging and Other Useful Tests; Fundus Autofluorescence, Fluorescein Angiography, and OCT; Psychophysical and Electrophysiological Testing; Differential Diagnosis; Choroideremia; Clinical Characteristics; Genetic Association and Pathophysiology; Ophthalmoscopic Features; Imaging and Other Useful Tests; Differential Diagnosis; Central Degenerations
0
8
8
8
8
SUMMARY OR ABSTRACT
Text of Note
This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of "de-risking" that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.
ACQUISITION INFORMATION NOTE
Source for Acquisition/Subscription Address
Springer Nature
Stock Number
com.springer.onix.9783030052225
OTHER EDITION IN ANOTHER MEDIUM
Title
Cell-based therapy for degenerative retinal disease.